Perone Thomas Michael
Insider CIK 1771761 · OVID SVP, General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OVID Ovid Therapeutics Inc. | A Award deriv | 2024-02-22 | 2024-02-26 | 168,750 | — | $0 | 168,750 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award | 2024-02-22 | 2024-02-26 | 28,125 | — | $0 | 28,125 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2023-02-23 | 2023-02-27 | 175,000 | — | $0 | 175,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2022-04-08 | 2022-04-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2022-04-08 | 2022-04-12 | 25,399 | — | $0 | 25,399 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2022-02-03 | 2022-02-04 | 175,000 | — | $0 | 175,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2020-12-17 | 2020-12-21 | 175,000 | — | $0 | 175,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2020-11-25 | 2021-04-29 | 44,000 | — | $0 | 44,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2020-10-11 | 2020-10-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2020-01-01 | 2020-01-02 | 75,000 | — | $0 | 75,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2019-12-18 | 2019-12-20 | 100,000 | — | $0 | 100,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2019-04-03 | 2019-04-08 | 125,000 | — | $0 | 125,000 | SEC↗ |